KTTA — Pasithea Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Pasithea Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.244	53	33.1	16.3	6.92
Net Total Accounts Receivable
Net Total Receivables	—	—	0.302	0.041	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.248	53.3	34.1	16.7	7.37
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	0.02	1.25	0.22	0.122
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	0.248	53.3	45.2	26.1	16.1
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.007	0.447	1.88	2.63	1.12
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.007	1.9	2.68	2.72	1.28
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.241	51.4	42.5	23.4	14.8
Total Liabilities & Shareholders' Equity	0.248	53.3	45.2	26.1	16.1
Total Common Shares Outstanding